India to United States Of America: Clindamycin Export Trade Route

The India to United States Of America Clindamycin corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $59.1K USD. The route is dominated by AUROBINDO PHARMA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's clindamycin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $29.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with clindamycin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #10 among India's top clindamycin export destinations globally.

On the import side, key buyers of Indian clindamycin in United States Of America include NORTHSTAR HEALTHCARE. NORTHSTAR HEALTHCARE is the single largest importer with 2 shipments valued at $59.1K USD.

India's clindamycin exports to United States Of America are driven primarily by a handful of large-scale manufacturers. AUROBINDO PHARMA LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in United States Of America benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AUROBINDO PHARMA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $29.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as clindamycin palmitate hydrochloride fororal solution usp 75mg/5ml (18192 x 1 spack), suggesting that buyers in United States Of America tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NORTHSTAR HEALTHCARE is the largest importer with 2 shipments worth $59.1K USD — representing 100% of all clindamycin imports from India on this route.